Susan G. Komen Chicago commits $787,500 in 2020 to decrease breast cancer mortality gap, increase access to care for communities in greatest need

The University of Illinois Cancer Center has been designated to lead the new Chicago Health Equity Initiative (CHEI), a cohort of Chicago-area medical leaders who support healthcare systems’ transformation.Funded by Susan G. Komen Chicago, the CHEI is comprised of three Federally Qualified Health Centers (Access Community Health Network, Erie Family Health Centers and Friend Family Health Center), six major health systems in Cook County (Cook County Health and Hospital System, University of Chicago…

Continue Reading

Kuchay’s latest grant continues his work on studying the ubiquitin-proteasome system

University of Illinois Cancer Center member Shafi Kuchay has received a five-year federal grant presented to outstanding investigators to further understand how cancer develops through the ubiquitin-pathway system, which regulates scores of cellular processes by ensuring timely and accurate protein removal when the proteins are no longer needed or when their function and/or structure have been compromised. Cell membranes house critical molecular targets which function irregularly in diseases such as cancer, neurodegenerative, cardiac,…

Continue Reading

DOD grant trying to close gap between Black and white men with prostate cancer

Larisa Nonn has received a grant from the U.S. Department of Defense to understand why a large gap exists between Black and white men being diagnosed with prostate cancer. Black men contract the disease at a younger age, the growth is more aggressive in nature, and causes twice as many deaths.  “Given the younger age and more aggressive the disease, it is likely there are biological underpinnings of prostate cancer distinct in African…

Continue Reading

MD/PhD student aspires to lessen severity of pancreatic cancer

Daniel Principe is working to make the words ‘pancreatic cancer’ less foreboding. “Pancreatic cancer has a dismal prognosis, with a median survival time of six to 12 months,” said Principe, a MD/PhD student at the University of Illinois College of Medicine who has received a Ruth L. Kirschstein National Research service F30 award from the National Cancer Institute (NCI) to fund a research project on the disease. “This is largely attributed to the…

Continue Reading

Small device could have big impact in ovarian cancer research

The small, handheld device Alexandria Young is helping create may look unusual and rudimentary to some, but she believes it has the ability to save the lives of women suffering from high grade serous ovarian cancer, the most lethal form of gynecologic cancer.A MD/PhD student at the University of Illinois College of Medicine, Young is assisting researchers at the University of Illinois at Chicago, Northwestern University and Charles Stark Draper Laboratory in producing…

Continue Reading

microRNAs could be used to predict treatments for prostate cancer

Prostate cancer is a tricky disease to treat, as it is hard to know which patients have aggressive tumors and which do not. Morgan Zenner is hoping a new test she is developing will change that. Zenner, a MD/PhD student at the University of Illinois at Chicago, has received a Ruth L. Kirschstein National Research service F30 award from the National Cancer Institute to determine how microRNAs in extracellular vesicles circulating in the…

Continue Reading

Program to address opioid prescribing for lung, head and neck cancer patients

The University of Illinois at Chicago has received a grant from the Coleman Foundation to develop a screening process for prescribing opioids and managing opioid use disorders in cancer patients who receive care at UI Health, UIC’s clinical health enterprise. More than 70% of cancer patients use opiates following radiation treatment, said Lawrence Feldman, MD, UIC professor of hematology/oncology at the College of Medicine and principal investigator. A significantly higher rate of opiate…

Continue Reading

UI Cancer Center awarded Bristol-Myers Squibb grant

A $1.5 million grant from the Bristol-Myers Squibb Foundation will support the University of Illinois Cancer Center’s efforts to reduce cancer disparities in Chicago. The three-year funding award will be used to develop population-specific cancer prevention and screening programs at community hospitals or health centers in three Chicago neighborhoods – Austin, Humboldt Park and South Shore. The programs will rely on community navigators to reach more than 600 people living in these high-need…

Continue Reading

UIC DPI grants awarded to two UI Cancer Center members

Two University of Illinois Cancer Center members were named winners of the UIC Discovery Partners Institute (DPI) Cycle 1 Seed Funding Program. Eighty eight proposals were submitted for consideration. The applications were reviewed by at least three UIC faculty, with proposals scoring in the top 30 percent advancing to a second round of review conducted by the Office of Technology Management to assess intellectual property and commercialization potential. A final review committee selected…

Continue Reading

UI Cancer Center applying for ACS grant

The UI Cancer Center is applying for a prestigious American Cancer Society – Institutional Review Grant (ACS-IRG) that is due April 1. The ACS-IRG is designed to support the development of beginning investigators conducting cancer research by providing pilot funds to obtain preliminary results that will enable them to compete successfully for national research grants. The program is intended to support independent, self-directed, investigators early in their careers for whom the institution has committed…

Continue Reading